Hints and tips:
Related Special Reports
The FT’s fifth annual ranking of the region’s businesses by revenue growth. Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
Deal with Atlas SP comes after private capital group acquired unit from Credit Suisse
...Rahul Titus, global head of influence at Ogilvy PR, said health influence was the “new frontier” in marketing....
...Soriot already earns more than bosses of larger European pharmaceutical companies....
...Englander has built Millennium into a hedge fund that increasingly resembles the markets division of a global bank....
...Last year, a number of UK companies, including veterinary pharmaceuticals company Dechra and the restaurant group behind Japanese dining chain Wagamama, were acquired by buyout firms....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...The focus on diagnosing diseases that are more common among older people is increasing as global demographics change....
...The cumulative impact is that there are easier places for global manufacturers to supply....
...This has led to western pharmaceutical regulators struggling to enforce oversight of Chinese manufacturers....
...Over the decades, studies have repeatedly shown these gender disparities persisting: men are more likely to be prescribed painkillers while women have to make do with psycho-pharmaceutical interventions....
...The World Health Organization has identified antimicrobial resistance as one of the top 10 global public health threats....
...US private equity group Apollo Global is in discussions with Sony Pictures Entertainment about making a joint takeover bid for Paramount Global that would rival ongoing talks between controlling shareholder...
...In today’s newsletter: Tiger Global goes on the offensive Financiers pay homage to a Rothschild Dimon and debt at a packed Miami conference Tiger Global reflects on a ‘solid recovery year’ Chase Coleman...
...“This industry is a global industry and a lot of the talent is based in the US.”...
...Actinium, the radioactive element on which Fusion’s drug is based, has a half-life of 11 days, making global supply “manageable”, according to Galbraith....
...Opec+ has undertaken voluntary production cuts since November 2022 — despite vehement US opposition — in order to boost global oil prices amid tepid global demand....
...“In a way it’s an arms race,” Russell Hardy, chief executive of Vitol, the world’s biggest oil trader, told the FT Commodities Global Summit in Lausanne this month....
...Tiger Global has raised $2.2bn for its latest venture capital fund, roughly a third of the $6bn target it touted to investors when it first announced the fund in 2022....
...There was, however, only one person being tried: Mohammed Ali Rashid, a former senior partner at Apollo Global Management....
...“The decline reflects, in no small part, the ongoing fall-off in demand for Covid-related pharmaceutical products,” finance minister Michael McGrath said in a statement, noting a “marked softening in global...
...Apparently, Apollo Global Management has other priorities....
...Longer term, as populations age and chronic conditions rise, global growth in demand for medicines is likely to put further strain on supply chains....
...In our view, a spate of technological breakthroughs is in the process of transforming not only the global economy but also financial markets....
...This is an audio transcript of the Behind the Money podcast episode: ‘Ozempic’s unconventional origins’ Michela Tindera It’s November, and the FT’s global pharmaceutical editor Hannah Kuchler is in Copenhagen...
International Edition